Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Clinical trials testing Vaccine plus Tpoxx
Primary completion date 7-31-22
https://ichgcp.net/clinical-trials-registry/NCT04957485
This sentiment is shared by Phillip Gomez, CEO of SIGA Technologies, Inc., which makes TPOXX (tecovirimat), an antiviral being used against monkeypox.
https://bio.news/health/we-have-monkeypox-treatments-but-must-act-fast-phillip-gomez-siga-technologies-tpoxx/
$SIGA
The INRB and the ANRS |Emerging Infectious Diseases/INSERM in collaboration with WHO are organizing a consultation Towards the development of a global CORE protocol for evaluation of treatments for hMPXV on 10-11 July 2022.
https://www.who.int/news-room/events/detail/2022/07/10/default-calendar/towards-the-development-of-a-global-core-protocol-for--evaluation-of-treatments-for-hmpxv-leveraging-the-congolese-experience
Portugal confirms first female case of monkeypox
https://en.trend.az/world/europe/3619294.html
Impressive climb... June 14th = Low $115.89 to present price.
Taiwan to receive 2nd-generation Moderna COVID vaccines in October. US expected to complete emergency use authorization process in late September or October.
gonna break that 10,000 psychological barrier likely Monday when case numbers are reported.
The WHO will have absolutely NO choice but to declare an international emergency...once they pull their head out of their ass!!!!!!!
Meet ‘Centaurus,’ the new ‘stealth Omicron.’ It was just found in the U.S. and may escape immunity more than any other COVID strain
https://finance.yahoo.com/news/meet-centaurus-stealth-omicron-just-185116816.html
Free Float reduced to 295M shares ! This will fly so much !
Spain has been forced to distance itself from the European Health Emergency Response Authority (HERA) to speed up the arrival of Tecovirimat
Medical Technologies, Inc. (“Meridian”, a Pfizer Company), SIGA’s partner for international promotion of TPOXX
There is new evidence that some people may be infected with monkeypox without having symptoms of the virus, suggesting it could be spreading far more widely than currently understood!
The only treatment drug specifically mentioned on the CDC website foe monkeypox is TPOXX which manufactures$$$$$$$$$
$SIGA
The Oxford study examining Tecovirimat's efficacy against monkeypox should be published very soon. I'm wondering if someone got a look at a preprint and the news is very good. Would explain why Siga is the only MP play soaring$$$$$
https://www.newscientist.com/article/2321790-smallpox-drug-helped-treat-monkeypox-in-one-uk-patient-in-2021/
BIG NEWS IMMINENT: WHO to hold another emergency monkeypox meeting week of July 18 or sooner as cases skyrocket globally
https://fortune.com/2022/07/06/monkeypox-emergency-committee-who-world-health-organization-july-18/
An Epstein-Barr Virus (EBV) vaccine clinical trial:
https://connect.trialscope.com/studies/d3d75c1e-070d-4736-87da-9127dc5187e6
This is an article about the molecular pathway targeted by Siga's antiviral drug. Tecorivimat
https://www.asbmb.org/asbmb-today/science/052422/is-there-a-mystery-in-the-monkeypox-antiviral
New Order over the weekend SIGA:
As monkeypox cases continue to soar, Spain 🇪🇸 decided to stay proactive and ahead of HERA and purchase an antiviral for monkeypox on its own called tecovirimat to help treat people contracting the virus.
— Monkeypoxtally (@Monkeypoxtally) July 4, 2022
tecovirimat is an FDA approved smallpox drug that helps to treat monkeypox.
Could This Send Moderna's Stock Soaring Back to $400:
https://www.fool.com/investing/2022/06/30/could-this-send-modernas-stock-soaring-back-to-400/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
Big one is this $629m BARDA upto 2028
https://investor.siga.com/news-releases/news-release-details/siga-technologies-awarded-barda-contract-tpoxxr
we are coming up on a 3 day weekend,
Every single day we are closer to PR bombs...contracts, data readout from clinical trial, manufacturing expansion, huge government pile of cash!
$SIGA
Monkeypox emergency committee reconvened by WHO due to ‘evolving situation’
pandemic
The World Health Organization will reconvene an emergency committee on monkeypox due to the “evolving situation,” Director-General Dr. Tedros Adhanom Ghebreyesus said Wednesday—this coming after the organization declared Saturday that the virus wasn’t an international public health emergency “at present.”
“They advised that I should reconvene them quickly based on the evolving situation, which I will do,” Adhanom Ghebreyesus said at a press availability, adding that the virus is potentially poised to “move into high-risk groups including children, the immunocompromised, and pregnant women.”
“We are starting to see this with several children already infected,” he said.
https://fortune.com/2022/06/29/monkeypox-emergency-committee-reconvened-by-who-due-to-evolving-situation/amp/
$SIGA Tecovirimat
Tpoxx now approved in france. I smell a EU deal looming:
https://blazetrends.com/monkey-pox-what-is-tecovirimat-the-new-drug-authorized-in-france/
CDC Activates Emergency Operations Center for Monkeypox Response
https://www.cdc.gov/media/releases/2022/s0628-monkeypox-eoc.html
First case of monkeypox in children found in France:
https://equalocean.com/briefing/20220627230147488
Monkeypox virus first detected in a child
The monkeypox virus has been detected in a child for the first time in the Netherlands:
https://www.ad.nl/binnenland/voor-het-eerst-apenpokkenvirus-vastgesteld-bij-een-kind~a6d6ee81/?referrer=https%3A%2F%2Ft.co%2F&referrer=https%3A%2F%2Fstocktwits.com%2F
BAD NEWS!
The WHO has strongly encouraged countries to “review the evidence and develop policy recommendations for the use of vaccines as relevant to the national context.”
It also called on countries to share any data from clinical studies on vaccines and stated that an antiviral drug called Tecorivimat was being studied and expected to be safe for protecting against monkeypox.
https://www.thejournal.ie/monkeypox-who-uk-data-5801742-Jun2022/
$SIGA
TODAY: Vaccines and Related Biological Products Advisory Committee June 28, 2022 Meeting Announcement
https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-28-2022-meeting-announcement
COVID-19 positive patients at higher risk of developing neurodegenerative disorders, new study shows:
The study, which analyzed the health records of over half of the Danish population, found that those who had tested positive for COVID-19 were at an increased risk of Alzheimer's disease, Parkinson's disease, and ischemic stroke.
https://medicalxpress.com/news/2022-06-covid-positive-patients-higher-neurodegenerative.html
Moderna seeking Hong Kong regulatory approval for Omicron-targeted Covid-19 booster vaccine
https://www.scmp.com/news/hong-kong/health-environment/article/3183127/moderna-seeking-hong-kong-regulatory-approval
Taiwan in talks to buy vaccine, medication for monkeypox
https://focustaiwan.tw/society/202206270023
WHO making same mistake as with Covid19, delay in calling Mockeypox a pandemic all but ensures that the situation will get much worse. Mockeypox cases are SOARING around the world. By the time WHO wakes up, we have a PANDEMIC.
RELAX MULTIBAGGER $SIGA
THE COMPANY is well-positioned for decades to come thanks to its cash hoard and rich pipeline. At current levels, this biotech stock can indeed make investors richer$$$$$$$$$$$
Moderna has the funds to advance its pipeline programs thanks to its success in the coronavirus market!
Expect the company to record key clinical wins in the next two years....
the flu, cytomegalovirus, Zika virus, and several forms of cancer.
The green flag: A booster that works
Moderna recently reported that its booster candidate offers "superior" performance against the omicron variant. The vaccine lifted a measure of neutralizing antibody activity eight-fold one month after vaccination, trial data show. This means the booster candidate handles the omicron variant even better than Moderna's coronavirus vaccine. And the candidate also protects against the original coronavirus. Moderna said this potential product is effective against omicron subvariants BA.4 and BA.5 too.
The biotech company is submitting the data to the U.S. Food and Drug Administration (FDA) for consideration. An FDA advisory committee is set to meet on June 28 to discuss whether it's necessary to update current vaccines for fall to target new strains -- or just stick with those original vaccines. Strong data from Moderna could weigh in favor of an update. This would be excellent news for the company. That's because Moderna appears to be closest to the finish line compared to rivals. Pfizer, too, is working on an updated shot -- but the big pharma player hasn't yet released data.
D.E.Shaw takes 5% ownership in SIGA. Shared Dispositive Power 3,634,392
Great firm well respected!
$SIGA
new:
https://fintel.io/doc/sec-d-e-shaw-co-lp-1010086-sc-13g-2022-june-24-19167-4003
Covid-19 vaccines prevented nearly 20 million deaths in a year, study estimates
https://www.statnews.com/2022/06/23/covid19-vaccines-prevention-global-deaths/#:~:text=Health-,Covid%2D19%20vaccines%20prevented%20nearly%2020%20million,in%20a%20year%2C%20study%20estimates&text=Covid%2D19%20vaccines%20cut,in%20The%20Lancet%20Infectious%20Diseases.
9.42% % of Shares Held by All Insider
64.00% % of Shares Held by Institutions
70.66% % of Float Held by Institutions
Shares
Owned CEO 29,881,508
BIG COMPANY
CDC panel endorses Moderna two-dose COVID vaccine for kids ages 6 to 17
https://thehill.com/policy/healthcare/3534860-cdc-panel-endorses-moderna-two-dose-covid-vaccine-for-kids-ages-6-to-17/
MRNA manufacturing variant vaccine ahead of regulatory approval shows a lot of confidence they will get contracts from many countries. Again, the company has the capability to mass produce and is creating a moat by having a physical presence in key countries. Cannot emphasize enough that manufacturing and distributing is key and Moderna has the dollars to invest in this.
This is at least another 50 billion sales!!!!!!!!
Moderna's COVID-19 variant vaccine will be ready to ship in August as the company has been making shots ahead of approval, Chief Executive Stephane Bancel told Reuters on Wednesday, adding that the only bottleneck to supply was a regulatory one.
"Our goal is as early as August given we're going to file all the data in June, by the end of June... hopefully in the August timeframe, the vaccine is authorised," Bancel said in an interview.
"We can start shipping in the August timeframe. Some countries might be September, but that will really be a regulatory decision. Because what is (the) bottleneck now is regulatory. From a manufacturing standpoint, we are making the vaccine."
Remember, UK is only announcing numbers on Tuesday and Friday now. Tomorrow’s number could be 350-400 new cases in just the UK alone. Tuesday’s number was 219...
Do not sell this stock trades its whole float of 38 M (about) every four days. It would be an insane squeeze if everyone held.
The hunt for more monkeypox antiviral , Siga, the small company that makes the antiviral tecovirimat, has been talking with Biden administration officials about expanding manufacturing capacities, including possibly opening a second manufacturing site, CEO Phillip Gomez told Global Pulse.
https://www.politico.com/newsletters/global-pulse/2022/06/23/the-hunt-for-more-of-a-monkeypox-antiviral-00041539
it’s going to pop big soon..can’t be contained....
The World Health Network (WHN) has announced Monkeypox outbreak a pandemic.
The WHO would hold an emergency meeting on June 23 to determine whether to classify the global monkeypox outbreak as a public health emergency of international concern.
$SIGA